日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.

EGFR突变型和野生型非小细胞肺癌中抗体药物偶联靶点的定量蛋白表达

Trontzas Ioannis P, He Mengni, Wurtz Anna, Robbins Charles J, Robinson Nathaniel, Bates Katherine, Liu Matthew, Aung Thazin N, Scott Liam, Chan Nay, Burela Sneha, Schillo Jacob, Liebler Daniel C, Hill Salisha, Morrison Ryan D, Vathiotis Ioannis, Syrigos Konstantinos N, Goldberg Sarah B, Politi Katerina, Rimm David L

Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer

EGFR突变型肺癌患者中,多个抑癌基因的共存改变与较差的预后相关

Stockhammer, Paul; Grant, Michael; Wurtz, Anna; Foggetti, Giorgia; Expósito, Francisco; Gu, Jianlei; Zhao, Hongyu; Choi, Jungmin; Chung, Sangyun; Li, Fangyong; Walther, Zenta; Dietz, Julia; Duffield, Emily; Gettinger, Scott; Politi, Katerina; Goldberg, Sarah B

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

奥希替尼治疗携带罕见EGFR 19号外显子缺失突变的肺癌患者的疗效

Grant, Michael J; Aredo, Jacqueline V; Starrett, Jacqueline H; Stockhammer, Paul; van Alderwerelt van Rosenburgh, Iris K; Wurtz, Anna; Piper-Valillo, Andrew J; Piotrowska, Zofia; Falcon, Christina; Yu, Helena A; Aggarwal, Charu; Scholes, Dylan; Patil, Tejas; Nguyen, Christina; Phadke, Manali; Li, Fang-Yong; Neal, Joel; Lemmon, Mark A; Walther, Zenta; Politi, Katerina; Goldberg, Sarah B

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

EGFR突变型腺癌转化为小细胞肺癌和其他神经内分泌癌:临床结果

Marcoux, Nicolas; Gettinger, Scott N; O'Kane, Grainne; Arbour, Kathryn C; Neal, Joel W; Husain, Hatim; Evans, Tracey L; Brahmer, Julie R; Muzikansky, Alona; Bonomi, Philip D; Del Prete, Salvatore; Wurtz, Anna; Farago, Anna F; Dias-Santagata, Dora; Mino-Kenudson, Mari; Reckamp, Karen L; Yu, Helena A; Wakelee, Heather A; Shepherd, Frances A; Piotrowska, Zofia; Sequist, Lecia V

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer

26例晚期非小细胞肺癌患者获得性PD-1轴抑制剂耐药的临床特征及治疗

Gettinger, Scott N; Wurtz, Anna; Goldberg, Sarah B; Rimm, David; Schalper, Kurt; Kaech, Susan; Kavathas, Paula; Chiang, Anne; Lilenbaum, Rogerio; Zelterman, Daniel; Politi, Katerina; Herbst, Roy S

Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells

致癌性EGFR抑制TET1 DNA去甲基化酶,从而诱导癌细胞中抑癌基因的沉默

Forloni, Matteo; Gupta, Romi; Nagarajan, Arvindhan; Sun, Li-Sha; Dong, Yuying; Pirazzoli, Valentina; Toki, Maria; Wurtz, Anna; Melnick, Mary Ann; Kobayashi, Susumu; Homer, Robert J; Rimm, David L; Gettinger, Scott J; Politi, Katerina; Dogra, Shaillay Kumar; Wajapeyee, Narendra

Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer

NF1表达降低会导致肺癌对EGFR抑制剂产生耐药性。

de Bruin, Elza C; Cowell, Catherine; Warne, Patricia H; Jiang, Ming; Saunders, Rebecca E; Melnick, Mary Ann; Gettinger, Scott; Walther, Zenta; Wurtz, Anna; Heynen, Guus J; Heideman, Daniëlle A M; Gómez-Román, Javier; García-Castaño, Almudena; Gong, Yixuan; Ladanyi, Marc; Varmus, Harold; Bernards, René; Smit, Egbert F; Politi, Katerina; Downward, Julian